4D Molecular Therapeutics Inc <FDMT.O>: B. Riley initiates coverage with Buy rating; target price $37
FDMT•Related News
Chime to cut 10% of total workforce on AI driven efficiencies, source says
CHYM•
BP Appoints Ian Tyler As Chair Of Nomination And Governance Committee
BP•
North European Oil Royalty Trust declares $0.26 per unit fiscal Q3 2026 distribution
NRT•
Enbridge CEO Sees Best Environment For Growth In Current Memory
ENB•
Linde CEO: Electronics Pipeline Is Looking Healthy At This Point In Time - Conf Call
LIN•